Log in to save to my catalogue

Rutaecarpine induces the differentiation of triple-negative breast cancer cells through inhibiting f...

Rutaecarpine induces the differentiation of triple-negative breast cancer cells through inhibiting f...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_27f85126c65746f5859e00bfdc93205b

Rutaecarpine induces the differentiation of triple-negative breast cancer cells through inhibiting fumarate hydratase

About this item

Full title

Rutaecarpine induces the differentiation of triple-negative breast cancer cells through inhibiting fumarate hydratase

Publisher

London: BioMed Central Ltd

Journal title

Journal of translational medicine, 2023-08, Vol.21 (1), p.1-553, Article 553

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Triple-negative breast cancer (TNBC) is one of the most aggressive human cancers and has poor prognosis. Approximately 80% of TNBC cases belong to the molecular basal-like subtype, which can be exploited therapeutically by inducing differentiation. However, the strategies for inducing the differentiation of TNBC remain underexplored. Met...

Alternative Titles

Full title

Rutaecarpine induces the differentiation of triple-negative breast cancer cells through inhibiting fumarate hydratase

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_27f85126c65746f5859e00bfdc93205b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_27f85126c65746f5859e00bfdc93205b

Other Identifiers

ISSN

1479-5876

E-ISSN

1479-5876

DOI

10.1186/s12967-023-04396-w

How to access this item